Amarin Corp Plc (AMRN)

[ziploc_1]

I am eagerly awaiting positive results from the Respect and Mitigate studies, but I doubt that Dr. Nissen's ego will ever let him publicly backtrack from his statements that MO played an pivotal role in Vascepa's successful R-IT studies....He will now conjure up reasons as to why Respect and Mitigate are not to be "Respected", even though no MO was used in these studies.

And he will still say the his former junior associate, now a professor at Harvard Medical School, was wrong.